Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California. Show more
Location: 701 Anacapa Street, Santa Barbara, CA, 93101, United States | Website: https://phytanix.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
3.971M
52 Wk Range
$1.88 - $15.26
Previous Close
$2.06
Open
$1.93
Volume
78,465
Day Range
$1.83 - $2.02
Enterprise Value
6.236M
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
11.21%
Institutional Own.
10.11%
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
PT00114 Details Addiction, Post-traumatic stress disorder, Treatment Resistant Depression, Social Anxiety Disorder | Phase 1/2 Data readout |
